Nuvation Bio, Inc. (NUVB)
4.78
+0.03
(+0.63%)
USD |
NYSE |
May 29, 16:00
4.75
-0.03
(-0.63%)
Pre-Market: 20:00
Nuvation Bio EPS Diluted (Quarterly) : 0.0143 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0482 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| Harrow, Inc. | -0.7414 |
| Alumis, Inc. | -0.7441 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.397M |
| Revenue (Quarterly) | 83.23M |
| Total Expenses (Quarterly) | 77.83M |
| Enterprise Value | 1.348B |
| Gross Profit Margin (Quarterly) | 92.16% |
| Profit Margin (Quarterly) | 6.48% |
| Earnings Yield | -8.96% |
| Normalized Earnings Yield | -9.065 |